Therapeutic Asset Ratings

3,272 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Epinephrine Cervical Cancer	National Cancer Institute (NCI)	P1/2	CC (41)
Immunotherapic Bifunctional Fusion Protein Comprised Of A Fully Human Igg1 Monoclonal Antibody (Avelumab) Against Human Programmed Death-Ligand 1 (Pd-L1) Fused To The Soluble Extracellular Domain Of Transforming Growth Factor-.Beta. (Tgf-.Beta.) Receptor Ii, Which Acts As A Tgf-.Beta. Trap Colon Carcinoma	National Cancer Institute (NCI)	P1/2	CC (41)
Nogapendekin Alfa Inbakicept Carcinoma	National Cancer Institute (NCI)	P1/2	CC (41)
Olaparib Colorectal Neoplasm	National Cancer Institute (NCI)	P1/2	CC (41)
pds01adc Cervical Cancer	National Cancer Institute (NCI)	P1/2	CC (41)
pds01adc Colon Carcinoma	National Cancer Institute (NCI)	P1/2	CC (41)
Prgn-2009 Cervical Cancer	National Cancer Institute (NCI)	P1/2	CC (41)
SX682 Head And Neck Cancer	National Cancer Institute (NCI)	P1/2	CC (41)
SX682 Colorectal Cancer	National Cancer Institute (NCI)	P1/2	CC (41)
Valemetostat Lung Cancer	National Cancer Institute (NCI)	P1/2	CC (41)
Cabozantinib Wilms Tumor	National Cancer Institute (NCI)	P2	CC (40)
Cabozantinib Lip And Oral Cavity Carcinoma	National Cancer Institute (NCI)	P2	CC (40)
Immunoglobulin G1, Anti-(Human Cd Antigen Cd27) (Human Monoclonal Cdx-1127 Clone 1F5 Heavy Chain), Disulfide With Human Monoclonal Cdx-1127 Clone 1F5 .Kappa.-Chain, Dimer Relapsed/Refractory Diffuse Large B-Cell Lymphoma	National Cancer Institute (NCI)	P2	CC (40)
Anetumab Ravtansine Pancreatic Adenocarcinoma	National Cancer Institute (NCI)	P1	CC (40)
Autologous Ccr4 Car T Cells Angioimmunoblastic T-Cell Lymphoma	National Cancer Institute (NCI)	P1	CC (40)
Cetuximab Rhabdomyosarcoma	National Cancer Institute (NCI)	P1	CC (40)
Emavusertib Colorectal Adenocarcinoma	National Cancer Institute (NCI)	P1	CC (40)
Emavusertib Pancreatic Ductal Adenocarcinoma	National Cancer Institute (NCI)	P1	CC (40)
Kras Tcr-Transduced Pbl Digestive System Cancer	National Cancer Institute (NCI)	P1	CC (40)
Telaglenastat Plasma Cell Myeloma	National Cancer Institute (NCI)	P1	CC (40)
Tnhyp217 Car T Cells Neoplasm	National Cancer Institute (NCI)	P1	CC (40)
Tnhyp217 Car T Cells Ovarian Neoplasm	National Cancer Institute (NCI)	P1	CC (40)
Tnhyp217 Car T Cells Gastric Neoplasm	National Cancer Institute (NCI)	P1	CC (40)
Veliparib Carcinoma Of Esophagus	National Cancer Institute (NCI)	P1	CC (40)
Veliparib Urothelial Carcinoma	National Cancer Institute (NCI)	P1	CC (40)

Showing 3151 to 3175 of 3,272 assets

PreviousPage 127 of 131Next